All In Biotech

Drug Trial Radar · NCT00948818

Trial of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation

A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial of Linaclotide Administered Orally for 12 Weeks Followed by a 4-Week Randomized Withdrawal Period in Patients With Irritable Bowel Syndrome With Constipation

Last checked: Nov 19, 2026Latest source record: Jan 30, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 803 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

803

Actual

Start

Jul 2009

Primary completion

Jul 2010

Study completion Aug 2010

Sponsor

Lead sponsor
Forest LaboratoriesAbbVie (ABBV)
Sponsor type
Industry
Collaborators
Ironwood Pharmaceuticals, Inc.
First posted
Jul 29, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this trial is to determine the efficacy and safety of linaclotide administered to patients with irritable bowel syndrome with constipation (IBS-C). The primary efficacy parameter is the percentage of patients in each treatment group that meet the protocol definition for Abdominal Pain and Complete Spontaneous Bowel Movement (APC) Responder.

Conditions

  • Irritable Bowel Syndrome Characterized by Constipation

Interventions

  • Linaclotide 290 microgramsDrug

    Oral, once daily each morning at least 30 minutes before breakfast for the duration of the study

  • Matching placeboDrug

    Oral, once daily each morning at least 30 minutes before breakfast for the duration of the study

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Abdominal Pain and Complete Spontaneous Bowel Movement (APC) Responder, 9 Out of 12 WeeksTime frame: Change from Baseline to Week 12
  2. Complete Spontaneous Bowel Movement (CSBM) 3+1 Responder, 9 Out of 12 WeeksTime frame: Change from Baseline to Week 12
  3. Abdominal Pain Responder, 9 Out of 12 WeeksTime frame: Change from Baseline to Week 12
  4. Abdominal Pain and Complete Spontaneous Bowel Movement (APC) Responder, 6 Out of 12 Weeks.Time frame: Change from Baseline to Week 12

Locations

118 sites in 2 countries. Site status is shown where the registry gives one.

  • Forest Investigative Site 037

    Birmingham, Alabama

  • Forest Investigative Site 036

    Birmingham, Alabama

  • Forest Investigative Site 135

    Hueytown, Alabama

  • Forest Investigative Site 014

    Huntsville, Alabama

  • Forest Investigative Site 080

    Chandler, Arizona

  • Forest Investigative Site 053

    Mesa, Arizona

  • Forest Investigative Site 078

    Peoria, Arizona

  • Forest Investigative Site 101

    Phoenix, Arizona

  • Forest Investigative Site 128

    Phoenix, Arizona

  • Forest Investigative Site 051

    Scottsdale, Arizona

  • Forest Investigative Site 136

    Tucson, Arizona

  • Forest Investigative Site 087

    Tucson, Arizona

  • Forest Investigative Site 094

    Burbank, California

  • Forest Investigative Site 026

    Encinitas, California

  • Forest Investigative Site 096

    Foothill Ranch, California

  • Forest Investigative Site 057

    Los Angeles, California

  • Forest Investigative Site 097

    Mission Hills, California

  • Forest Investigative Site 005

    Orange, California

  • Forest Investigative Site 024

    Westlake Village, California

  • Forest Investigative Site 021

    Boulder, Colorado

  • Forest Investigative Site 019

    Colorado Springs, Colorado

  • Forest Investigative Site 034

    Denver, Colorado

  • Forest Investigative Site 074

    Longmont, Colorado

  • Forest Investigative Site 010

    Wheat Ridge, Colorado

  • Forest Investigative Site 058

    Waterbury, Connecticut

  • Forest Investigative Site 042

    Boca Raton, Florida

  • Forest Investigative Site 003

    Bradenton, Florida

  • Forest Investigative Site 137

    Brandon, Florida

  • Forest Investigative Site 070

    Brooksville, Florida

  • Forest Investigative Site 018

    Fort Myers, Florida

  • Forest Investigative Site 030

    Jupiter, Florida

  • Forest Investigative Site 077

    Kissimmee, Florida

  • Forest Investigative Site 133

    Miami, Florida

  • Forest Investigative Site 031

    Miami, Florida

  • Forest Investigative Site 129

    New Smyrna Beach, Florida

  • Forest Investigative Site 108

    Ocala, Florida

  • Forest Investigative Site 092

    Orlando, Florida

  • Forest Investigative Site 038

    Panama City, Florida

  • Forest Investigative Site 027

    Pembroke Pines, Florida

  • Forest Investigative Site 045

    St. Petersburg, Florida

Showing 40 of 118 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.